Faeth Therapeutics Stock (NASDAQ:FTH)
Previous Close
$25.00
52W Range
$6.33 - $36.76
50D Avg
$21.14
200D Avg
$17.02
Market Cap
$31.75M
Avg Vol (3M)
$55.37K
Beta
-0.23
Div Yield
-
FTH Company Profile
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]